Management team

GARCIA BUSTELO, XOSE RAMON Dirección

ORFAO DE MATOS CORREIA E VALE, JOSE ALBERTO Vicedirección

CLAVERO HERRERO, JUAN PABLO Gerencia

Headquarters

CAMPUS MIGUEL DE UNAMUNO,
Salamanca (Salamanca)
Spain,
923 29 47 20
http://www.cicancer.org/

Research groups

Ongoing projects

Knowledge transference

Services

A total of 20 Research groups belong to this institute

Grupo

Subárea

MITOTIC MEMBRANES AND GENOME INTEGRITY
Molecular genetics of cancer.
NOVEL RAS REGULATORS IN CANCER & HOMEOSTASIS
Oncohematology
Ras mediated signalling
RAS SIGNALING AND LUNG CANCER
Signalling by human serine-threonine kinases in cancer biology, neurodegeneration and DNA damage responses
Signalling by receptor tyrosine kinases
Structural Biology of Cell Adhesion and Signaling	http://xtal.cicancer.org/
TUMOUR-STROMA SIGNALING

A total of 31 Ongoing projects belong to this institute

MARKET-ORIENTED OPTIMIZATION OF INHIBITORS AGAINST THE CATALYTIC ACTIVITY OF THE VAV1 ONCOPROTEIN
MECHANO-CHEMICAL DETERMINANTS OF INTRACELLULAR FORCE GENERATION IN IMMUNE CELL MIGRATION AND DIVISION AND IN LYMPHOID MALIGNANCIES
MOLECULAR MECHANISMS OF CHROMOSOME SEGREGATION AND GAMETOGENESIS
MycoMatrix: ingeniería de un bioterapéutico vivo recombinante para normalizar la matriz extracelular tumoral en el cáncer de pulmón de células no pequeñas impulsado por KRAS
NOVEL ACTIVITIES OF THE AUTOPHAGIC REGULATOR ATG16L1 AND THEIR RELEVANCE IN HEALTH AND DISEASE
PHARMACOLOGICAL STRATEGIES TO PREVENT BREAST CANCER BY MODIFYING POSTLACTATIONAL INVOLUTION
POTENTIAL THERAPEUTIC LIABILITIES CAUSED BY THE IMPACT OF ONCOGENIC DRIVERS ON THE MICROENVIRONMENT OF LUNG TUMOURS
RHO GUANOSINE NUCLEOTIDE EXCHANGE FACTORS FRIENDS OR FOES IN CANCER?
ROLE OF THE HUMAN VRK1 KINASE SIGNALLING PATHWAY IN THE PATHOGENESIS OF CANCER AND NEURODEGENERATIVE DISEASES
Signalling by ErbB/HER receptors in cancer

A total of 2 investigators belong to this institute

No se han encontrado resultados para los filtros aplicados

A total of 22 Knowledge transference belong to this institute

MAMIFERO NO HUMANO MODIFICADO GENETICAMENTE CELULAS Y METODOS PARA PRODUCIRLAS
MAMÍFERO NO HUMANO MODIFICADO GENÉTICAMENTE CÉLULAS Y MÉTODOS PARA PRODUCIRLAS
METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES
METHODS AND KITS FOR THE PROGNOSIS OF SQUAMOUS CELL CARCINOMAS SCC
MODELOS ANIMALES Y CELULAS DERIVADAS PARA SU USO EN LA DETERMINACION DE COMPUESTOS UTILES EN EL TRATAMIENTO DE LINFOMAS DE CELULAS T
MODELOS ANIMALES Y CELULAS DERIVADAS PARA SU USO EN LA DETERMINACION DE COMPUESTOS UTILES EN EL TRATAMIENTO DE LINFOMAS DE CELULAS T
PASIREOTIDE OR A PHARMACEUTICAL ACCEPTABLE SALTOR SOLVATE THEREOF FOR USE IN PREVENTION OR DELAY OF BREAST CANCER IN A FEMALE MAMMAL
POLINUCLEOTIDO QUE LIMITA LA EXPRESION DEL ONCOGEN HUMANO TELAML 1 A CELULAS MADRE HEMATOPOYETICAS Y MODELO ANIMAL QUE LO CONTIENE
PROCEDIMIENTO PARA DISEÑAR UNA TERAPIA INDIVIDUAL ANTITUMORAL BASADO EN LA DETECCION DE LOS NIVELES DE PROTEINA HSP90 EL USO DE INHIBIDORES DE LA PROTEINA HSP90
PROCEDIMIENTO PARA DISEÑAR UNA TERAPIA INDIVIDUAL ANTITUMORAL BASADO EN LA DETECCION DE LOS NIVELES DE PROTEINA HSP90 EL USO DE INHIBIDORES DE LA PROTEINA HSP90 PARA LA ELBORACION DE COMPOSICIONES FARMACEUTICAS

A total of 13 services belong to this institute